Home > National Drug Code (NDC) > Clindamycin Hydrochloride

Clindamycin Hydrochloride - 0591-3120-16 - (Clindamycin Hydrochloride)

Alphabetical Index


Drug Information of Clindamycin Hydrochloride

Product NDC: 0591-3120
Proprietary Name: Clindamycin Hydrochloride
Non Proprietary Name: Clindamycin Hydrochloride
Active Ingredient(s): 300    mg/1 & nbsp;   Clindamycin Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Clindamycin Hydrochloride

Product NDC: 0591-3120
Labeler Name: Watson Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA063083
Marketing Category: ANDA
Start Marketing Date: 20030318

Package Information of Clindamycin Hydrochloride

Package NDC: 0591-3120-16
Package Description: 16 CAPSULE in 1 BOTTLE, PLASTIC (0591-3120-16)

NDC Information of Clindamycin Hydrochloride

NDC Code 0591-3120-16
Proprietary Name Clindamycin Hydrochloride
Package Description 16 CAPSULE in 1 BOTTLE, PLASTIC (0591-3120-16)
Product NDC 0591-3120
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Clindamycin Hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20030318
Marketing Category Name ANDA
Labeler Name Watson Laboratories, Inc.
Substance Name CLINDAMYCIN HYDROCHLORIDE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]

Complete Information of Clindamycin Hydrochloride


General Information